Qiuying Cheng Selected Research

Small Interfering RNA (siRNA)

9/2007

Forced expression of survivin-2B abrogates mitotic cells and induces mitochondria-dependent apoptosis by blockade of tubulin polymerization and modulation of Bcl-2, Bax, and survivin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiuying Cheng Research Topics

Disease

10	Malaria 04/2024 - 07/2019
6	Neoplasms (Cancer) 10/2016 - 09/2007
5	Anemia 09/2023 - 01/2020
4	COVID-19 08/2023 - 01/2020
4	Infections 08/2023 - 01/2020
3	Cardiotoxicity 10/2016 - 12/2010
1	Adenoviridae Infections (Adenovirus Infections) 04/2024
1	Brain Diseases (Brain Disorder) 08/2023
1	Shock 08/2023
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023
1	Bacteremia 01/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2018
1	Lung Neoplasms (Lung Cancer) 06/2012
1	Body Weight (Weight, Body) 01/2012
1	Down Syndrome (Down's Syndrome) 12/2010

Drug/Important Bio-Agent (IBA)

3	hemozoinIBA 04/2024 - 07/2019
3	insulin receptor-related receptor (IRR)IBA 09/2023 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 07/2019 - 06/2012
3	AnthracyclinesIBA 10/2016 - 12/2010
3	SurvivinIBA 01/2012 - 09/2007
2	Hemoglobins (Hemoglobin)IBA 09/2023 - 01/2021
2	daunorubicinolIBA 10/2016 - 07/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2015 - 01/2012
2	Carbonyl Reductase (NADPH)IBA 06/2012 - 12/2010
1	Silicon Dioxide (Silica)FDA LinkGeneric 04/2024
1	Natural Killer Cell ReceptorsIBA 09/2023
1	Natural Cytotoxicity Triggering Receptor 3IBA 09/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	Amino Acids FDA Link 01/2022
1	Complement C3 (C3 Complement)IBA 01/2022
1	Complement C5 (Complement 5)IBA 01/2022
1	artemisinin (artemisinine)IBA 10/2020
1	Neutralizing AntibodiesIBA 10/2020
1	Investigational DrugsIBA 10/2020
1	2-thioxo-4-thiazolidinecarboxylic acid (TTCA)IBA 01/2020
1	tyrosyl-tyrosyl-glutamyl-glutamic acidIBA 01/2020
1	ProstaglandinsIBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020
1	Complement C1q (C1q Complement)IBA 07/2019
1	lipoteichoic acidIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2018
1	adriamycinolIBA 07/2015
1	Daunorubicin (Cerubidine)FDA LinkGeneric 07/2015
1	SmokeIBA 06/2012
1	Messenger RNA (mRNA)IBA 06/2012
1	Benzo(a)pyreneIBA 06/2012
1	Gemcitabine FDA Link 01/2012
1	7- ethyl- 7- hydroxy- 10H- 1,3- Dioxolo(4,5- g)pyrano(3',4':6,7)indolizino(1,2- b)quinoline- 8,11(7H,12H)- dioneIBA 01/2012
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 01/2012
1	Fluorouracil (Carac)FDA LinkGeneric 01/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2012
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2012
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2012
1	sepantroniumIBA 01/2012
1	Docetaxel (Taxotere)FDA Link 01/2012
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2012
1	EnzymesIBA 12/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2007
1	Small Interfering RNA (siRNA)IBA 09/2007

Therapy/Procedure

3	Therapeutics 07/2023 - 10/2020
1	Artificial Respiration (Mechanical Ventilation) 08/2023
1	Length of Stay 01/2022
1	N95 Respirators 01/2020